4//SEC Filing
Hoppenot Herve 4
Accession 0001628280-25-016570
CIK 0000879169other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 4:49 PM ET
Size
6.1 KB
Accession
0001628280-25-016570
Insider Transaction Report
Form 4
INCYTE CORPINCY
Hoppenot Herve
DirectorChief Executive OfficerOther
Transactions
- Award
Common Stock
2025-04-01+66,899→ 563,573 total
Footnotes (2)
- [F1]Represents the shares of common stock underlying performance shares earned upon the achievement of performance criteria determined to be satisfied on April 1, 2025. The earned shares will vest on the third anniversary of the July 2, 2022 grant date, subject to the Reporting Persons continued service with the Issuer. Each performance share represents the right to receive one or more shares of common stock based on, and subject to, specified development, revenue and market-based (relative total shareholder returns compared to the Nasdaq Biotechnology Index) performance goals determined by the Issuers Compensation Committee in January 2022 as set forth in the Performance Share Award Agreement. The number of shares of common stock that the Reporting Person is entitled to receive over the three year performance period ranges from 0% to 150% of the number of performance shares awarded.
- [F2]This includes an aggregate of 181,595 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested.
Documents
Issuer
INCYTE CORP
CIK 0000879169
Entity typeother
Related Parties
1- filerCIK 0001596492
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 4:49 PM ET
- Size
- 6.1 KB